Latest Breaking News On - Simon glerup - Page 2 : comparemela.com

Novo Holdings Launches Muna Therapeutics with US$ 73M Series A to Advance Novel Small Molecule Therapeutics for Neurodegenerative Diseases - Novo Holdings created and built Muna Therapeutics with pioneers in the field of neurodegeneration - Led by an experienced management team of Entrepreneurs-in-Residence from Novo Seeds - Financing co-led by Novo Holdings, Sofinnova Partners, Droia Ventures and LSP Dementia Fund, with participation from Polaris Partners, Polaris Innovation Fund, Sanofi Ventures, V-Bio Ventures and VIB News provided by Share this article Share this article COPENHAGEN, Denmark, July 9, 2021 /PRNewswire/ Novo Holdings, a global life science investor, today announces that it has co-led the Series A financing of its portfolio company, Muna Therapeutics ( Muna ), which is pioneering the development of first-in-class small molecule therapeutics for neurodegenerative diseases. The financing also includes Sofinnova Partners, Droia Ventures and LSP Dementia Fund wi

Simon glerupAnders hinsbyMorten graugaardRita balice gordonNovo nordiskDementia fundPartner at novo holdingsNovo groupPolaris innovation fundPrnewswire novo holdingsNovo nordisk foundationNovo holdingsAarhus universityMuna therapeuticsSofinnova partnersDroia ventures